ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1584

Telemedicine Visits During COVID-19 Improved Clinic Show Rates

Reem Alkilany1 and Raymond Hong2, 1MetroHealth medical center, lakewood, OH, 2Metrohealth Medical center, Richfield, OH

Meeting: ACR Convergence 2020

Keywords: Access to care, COVID-19, Health Care, Health policy, quality of care

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: The COVID-19 pandemic has tremendously affected the healthcare sector. State of Ohio officials recommended to hold in-person outpatient visits and elective procedures to limit virus spread. Many patients with chronic illnesses had reduced access to healthcare, this prompted the necessity to take active steps to continue delivering healthcare while ensuring safety for both patients and healthcare providers.

The MetroHealth System is an academic, public health care institution that services the population of Cuyahoga County in Cleveland, OH. Within 1 week of the State of Ohio issuing a statewide order limiting gatherings in March 2020, the Rheumatology outpatient clinics implemented telemedicine by video or telephone limiting in person visit sonly when deemed medically necessary. Anecdotally, Rheumatology providers reported improved clinic show rates with telemedicine visits, prompting this quality improvement project.

Our aim is to investigate and compare completed visit, no show, and cancellation rates between in-person and telemedicine appointments to see if telemedicine has a beneficial impact on access to Rheumatology ambulatory clinics

Methods: Using Reporting Workbench in our Epic electronic health record, we collected data retrospectively pertaining to rheumatology outpatient appointments at the MetroHealth System between Jan 3-May 31, 2020 – a 20-week period. Appointments were allocated into 3 categories: canceled; no-show; and completed. Data was segmented into in-person versus telemedicine, weekly stratified. figures 1-3.

For analysis, the data was divided into two 10-week periods: period 1, the pre-COVID19 interval (Jan 3-Mar 15, 2020) and period 2, during COVID19 pandemic (Mar16-May 31, 2020). During period 1, the only modality was in-person visits, while during period 2 telemedicine started taking place in addition to in-person visits. Appointment Activity denoted the sum of cancellations, no shows, and completed visits. On-Schedule appointment totals summed no show and completed visits. Rates of cancelations, no shows, and completed visits were compared to Appointment Activity totals as well as On-Schedule totals.

Results: Telemedicine appointment cancellations were nearly zero (1 out of 825 telemedicine appointments offered) in the 10-week During COVID-19 period as compared to the pre-COVID-19 period where 527 appointments were cancelled, all in-person appointments. No shows also trended down in period 2 when there were 191 no shows (121 in-person and 70 telemedicine) versus 220 no shows in period 1 where only in-person visits were offered. This led to a slight increase in completed visits During COVID-19 when 1038 had a completed appointment (754 telemedicine and 284 in-person); whereas, pre-COVID-19 resulted in 930 completed in-person.

Conclusion: Barriers to accessing in-person healthcare because of transportation or other issues has been a challenge that might be conquered by telemedicine. The offering of telemedicine had seemingly favorable impacts on access to Rheumatology ambulatory clinics at our academic, public health system. We encourage examining the incorporation of telemedicine in our routine clinic visits to improve patient’s appointment adherence.

This graph illustrates overall cancelation rates: # canceled/ appointment activity (cancels + no shows + completed) – Period 1 is between Jan 3rd to Mar 15th, before the initial State of Ohio executive order responding to the COVID-19 pandemic – Period 2 is between Mar 16th – May 31st, immediately following the initial State of Ohio executive order responding to the COVID-19 pandemic

This graph illustrates completed visit rate per on-schedule appointments: # completed visits/ on-schedule appointments (completed visits+ no show). – Period one is between Jan 3rd to Mar 15th, before the initial State of Ohio executive order responding to the COVID-19 pandemic – Period two is between Mar 16th – May 31st, immediately following the initial State of Ohio executive order responding to the COVID-19 pandemic

This graph illustrates no-show rate per on-schedule appointments: # no show/on-schedule appointments (completed+ no show) – Period 1 is between Jan 3rd to Mar 15th, before the initial State of Ohio executive order responding to the COVID-19 pandemic – Period two is between Mar 16th – May 31st, immediately following the initial State of Ohio executive order responding to the COVID-19 pandemic


Disclosure: R. Alkilany, None; R. Hong, None.

To cite this abstract in AMA style:

Alkilany R, Hong R. Telemedicine Visits During COVID-19 Improved Clinic Show Rates [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/telemedicine-visits-during-covid-19-improved-clinic-show-rates/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/telemedicine-visits-during-covid-19-improved-clinic-show-rates/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology